Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMS USA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 26
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 20
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 27
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 26
  • 0 comments

FDA approve ISONIAZID

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 21
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MSD MERCK CO

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 26
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

B BRAUN MEDICAL INC

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 29
  • 0 comments

FDA approve BUPIVACAINE HYDROCHLORIDE

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 30
  • 0 comments

FDA approve ISONIAZID

Comment Full text

ITERUM THERAPEUTICS US LTD

  • FDA Approval
  • Oct. 25, 2024, 14:55 UTC
  • 31
  • 0 comments

FDA approve SULOPENEM ETZADROXIL;PROBENECID

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 28
  • 0 comments

FDA approve ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB

Comment Full text
  • Previous
  • 232
  • 233
  • 234
  • 235
  • 236
  • Next

Search

News categories

  • Technical Exchange News(9921)
  • Event(412)
  • SEC News(167881)
  • FDA Approval(9362)
  • Company Report(721)
  • Business News(111713)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin